Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,044,189
-$395,391 QoQ
Shares Held
32,186
-9.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#262
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $3,769,908,119 across 17 Drug Manufacturers - General names. NVS ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,750,788 | $2,099,947,825 | |
| 2 | ABBV |
AbbVie Inc.
|
2,151,394 | $541,376,786 | |
| 3 | JNJ |
Johnson & Johnson
|
1,943,962 | $493,708,029 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,500,619 | $192,829,541 | |
| 5 | AMGN |
Amgen Inc
|
438,431 | $158,764,633 | |
| 6 | PFE |
Pfizer Inc
|
4,509,295 | $108,583,823 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
719,424 | $90,892,028 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,140,161 | $65,696,076 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,044,189 | 32,186 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $5,439,580 | 35,611 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $4,272,453 | 30,989 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $4,175,366 | 32,559 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $3,005,767 | 24,839 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $2,667,159 | 23,925 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $4,314,920 | 44,342 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $5,440,561 | 47,301 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $5,010,646 | 47,066 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $5,864,256 | 60,625 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $5,970,860 | 59,135 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $6,214,071 | 61,006 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $6,186,893 | 61,311 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $6,102,912 | 66,336 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $6,113,983 | 67,394 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $5,112,508 | 67,261 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $6,250,148 | 73,940 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $6,800,098 | 77,494 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $6,847,239 | 78,281 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $6,492,105 | 79,385 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $7,562,336 | 82,884 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $7,434,452 | 86,973 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $8,359,982 | 88,531 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,726,222 | 88,848 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $7,835,271 | 89,710 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $7,393,126 | 89,668 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||